Champions Oncology (CSBR) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to -$80.1 million.
- Champions Oncology's Retained Earnings rose 300.12% to -$80.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$80.1 million, marking a year-over-year increase of 300.12%. This contributed to the annual value of -$79.9 million for FY2025, which is 555.72% up from last year.
- Latest data reveals that Champions Oncology reported Retained Earnings of -$80.1 million as of Q4 2025, which was up 300.12% from -$80.4 million recorded in Q3 2025.
- Champions Oncology's 5-year Retained Earnings high stood at -$71.6 million for Q1 2021, and its period low was -$84.6 million during Q2 2024.
- Moreover, its 5-year median value for Retained Earnings was -$77.7 million (2023), whereas its average is -$77.3 million.
- As far as peak fluctuations go, Champions Oncology's Retained Earnings tumbled by 1338.97% in 2023, and later soared by 757.4% in 2025.
- Over the past 5 years, Champions Oncology's Retained Earnings (Quarter) stood at -$72.4 million in 2021, then rose by 0.15% to -$72.3 million in 2022, then dropped by 13.39% to -$82.0 million in 2023, then decreased by 0.73% to -$82.6 million in 2024, then increased by 3.0% to -$80.1 million in 2025.
- Its last three reported values are -$80.1 million in Q4 2025, -$80.4 million for Q3 2025, and -$79.9 million during Q2 2025.